[go: up one dir, main page]

ES2197781A1 - Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. - Google Patents

Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Info

Publication number
ES2197781A1
ES2197781A1 ES200102705A ES200102705A ES2197781A1 ES 2197781 A1 ES2197781 A1 ES 2197781A1 ES 200102705 A ES200102705 A ES 200102705A ES 200102705 A ES200102705 A ES 200102705A ES 2197781 A1 ES2197781 A1 ES 2197781A1
Authority
ES
Spain
Prior art keywords
ibuprofen
weight per
per volume
pharmaceutical compositions
oral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200102705A
Other languages
English (en)
Other versions
ES2197781B1 (es
Inventor
Redondo Ana Maria Jimenez
Abanades Laura Berges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Priority to ES200102705A priority Critical patent/ES2197781B1/es
Priority to DE60217903T priority patent/DE60217903T2/de
Priority to AT02793140T priority patent/ATE352287T1/de
Priority to PCT/ES2002/000572 priority patent/WO2003047550A1/es
Priority to AU2002358819A priority patent/AU2002358819A1/en
Priority to EP02793140A priority patent/EP1452169B1/en
Publication of ES2197781A1 publication Critical patent/ES2197781A1/es
Application granted granted Critical
Publication of ES2197781B1 publication Critical patent/ES2197781B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones farmacéuticas líquidas de base acuosa en forma de suspensión para la administración por vía oral de ibuprofeno como principio activo que comprende de 0,8% a 6% en peso por volumen de ibuprofeno; de 0,1% a 2% en peso por volumen de cloruro sódico; de 0,01% a 0,5% en peso por volumen de sacarina sódica; de 0,1% a 2% en peso por volumen de uno o más agentes reguladores del pH en una cantidad suficiente como para ajustar el pH entre 3,8 y 4,8; de 0,01% a 0,5% en peso por volumen de un conservante; junto con una cantidad adecuada de otros excipientes farmacéuticamente aceptables de características viscosizantes y enmascarantes del sabor, así como un procedimiento para su preparación.
ES200102705A 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. Expired - Lifetime ES2197781B1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES200102705A ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
DE60217903T DE60217903T2 (de) 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
AT02793140T ATE352287T1 (de) 2001-12-04 2002-12-02 Flüssige pharmazeutische zusammensetzungen auf wasserbasis in suspensionsform zur oralen verabreichung von ibuprofen
PCT/ES2002/000572 WO2003047550A1 (es) 2001-12-04 2002-12-02 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno
AU2002358819A AU2002358819A1 (en) 2001-12-04 2002-12-02 Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
EP02793140A EP1452169B1 (en) 2001-12-04 2002-12-02 Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102705A ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Publications (2)

Publication Number Publication Date
ES2197781A1 true ES2197781A1 (es) 2004-01-01
ES2197781B1 ES2197781B1 (es) 2005-02-16

Family

ID=8499662

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200102705A Expired - Lifetime ES2197781B1 (es) 2001-12-04 2001-12-04 Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Country Status (6)

Country Link
EP (1) EP1452169B1 (es)
AT (1) ATE352287T1 (es)
AU (1) AU2002358819A1 (es)
DE (1) DE60217903T2 (es)
ES (1) ES2197781B1 (es)
WO (1) WO2003047550A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
DE202008006492U1 (de) 2007-02-23 2008-08-21 Basf Se Verwendung von wasserdispergierbaren Carotinoid-Nanopartikeln als Geschmacksmodulatoren, Geschmacksmodulatoren, enthaltend wasserdispergierbare Carotinoid-Nanopartikel
MX2009008019A (es) 2007-02-23 2009-08-07 Basf Se Uso de nanoparticulas carotenoides dispersibles en agua como moduladores de sabor, moduladores de sabor que contiene nanoparticulas carotenoides dispersibles en agua y metodo para modulacion de sabor.
CN101616607B (zh) * 2007-02-23 2014-06-04 B.R.A.I.N.生物技术研究与信息网络股份公司 含有至少一种高倍甜味剂(his)的物质组合物的调味方法
EP2142011B1 (de) 2007-02-23 2011-01-12 B.R.A.I.N. Biotechnology Research And Information Network AG Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
WO2009109226A1 (de) 2008-03-05 2009-09-11 Basf Se Verfahren zur geschmacksmodulation von stofflichen zusammensetzungen, die mindestens einen high intensity sweetener (his) enthalten
DE202008006164U1 (de) 2008-03-05 2008-10-02 Basf Se Verwendung eines Polyoxyethylensorbitanfettsäureesters zur Geschmacksmodulation von stofflichen Zusammensetzungen, die mindestens einen High Intensity Sweetener (HIS) enthalten
CN117883379A (zh) * 2021-02-12 2024-04-16 浙江贝灵生物医药有限公司 一种口服碱性溶媒组合物及其制备方法与应用
CN115671046B (zh) * 2022-10-10 2024-04-26 澳美制药(苏州)有限公司 布洛芬混悬滴剂及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048428T3 (es) * 1989-03-28 1994-03-16 American Home Prod Composiciones de ibuprofeno de administracion oral.
ES2064634T3 (es) * 1989-06-28 1995-02-01 Mcneil Ppc Inc Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
ES2039281T3 (es) * 1987-07-08 1995-04-01 American Home Prod Composiciones de ibuprofeno para uso en pediatria.
EP0684819A1 (fr) * 1993-12-20 1995-12-06 Guerry, Arlette Compositions pharmaceutiques liquides a base d'ibuprofene
US6231890B1 (en) * 1996-05-02 2001-05-15 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039281T3 (es) * 1987-07-08 1995-04-01 American Home Prod Composiciones de ibuprofeno para uso en pediatria.
ES2048428T3 (es) * 1989-03-28 1994-03-16 American Home Prod Composiciones de ibuprofeno de administracion oral.
ES2064634T3 (es) * 1989-06-28 1995-02-01 Mcneil Ppc Inc Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
EP0684819A1 (fr) * 1993-12-20 1995-12-06 Guerry, Arlette Compositions pharmaceutiques liquides a base d'ibuprofene
US6231890B1 (en) * 1996-05-02 2001-05-15 Taisho Pharmaceutical Co., Ltd. Suspension of sparingly water-soluble acidic drug

Also Published As

Publication number Publication date
ES2197781B1 (es) 2005-02-16
AU2002358819A1 (en) 2003-06-17
EP1452169A1 (en) 2004-09-01
ATE352287T1 (de) 2007-02-15
DE60217903D1 (de) 2007-03-15
WO2003047550A1 (es) 2003-06-12
DE60217903T2 (de) 2007-11-22
EP1452169B1 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
ATE331525T1 (de) Salzformarme polyallylamine
IL161290A0 (en) Stable composition comprising particles in a frozen aqueous matrix
PL358103A1 (pl) Hydrofilowe molekularne roztwory dyspersyjne karwedilolu
EA200400777A1 (ru) Фармацевтические композиции соединения платины
DK1227806T3 (da) Farmaceutisk præparat indeholdende tolterodin og dets anvendelse
ZA200205512B (en) Novel substituted benzimidazole dosage forms and methods of using same.
CY1111061T1 (el) Νεες ετεροκυκλικες ενωσεις δραστικες ως αναστολεις των βητα-λακταμασων
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NO20034863L (no) Deutererte 3-piperidinopropiofenon så vel som legemidler som inneholder disse forbindelser
MA27702A1 (fr) Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0102055D0 (sv) New Compounds
SE0102440D0 (sv) New compound
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.
YU46503A (sh) Farmaceutski oblik dronedarona za parenteralnu upotrebu
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
UY27373A1 (es) Formulaciones de interferón beta-humano
EE04264B1 (et) Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
BE2016C017I2 (es)
ATE288257T1 (de) Trinkbare pharmazeutische suspension von ibuprofen
ATE299027T1 (de) Verwendung von übersulfatierten polysacchariden als hiv-hemmer
ATE333877T1 (de) Amlopidinbezylat-tabletten mit verbesserter stabilität

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040101

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2197781B1

Country of ref document: ES